汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇(017951)资产负债表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
92,880.76 |
129,167.04 |
870,742.45 |
297,992.65 |
| 存出保证金 |
5,753.25 |
45,787.63 |
59,562.07 |
27,083.37 |
| 交易性金融资产 |
490,928,658.43 |
434,711,447.26 |
348,846,337.09 |
294,467,740.92 |
| 其中:股票投资 |
- |
- |
- |
- |
| 债券投资 |
- |
1,111,741.26 |
2,923,282.69 |
2,310,068.96 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
31,990.68 |
- |
- |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
17,932,721.49 |
4,509,574.85 |
7,310,687.48 |
- |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
543,467,335.25 |
470,166,859.22 |
380,665,678.28 |
314,023,758.08 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
5,000,842.48 |
- |
- |
- |
| 应付赎回款 |
13,433,816.65 |
10,719,056.45 |
10,932,973.31 |
3,539,501.37 |
| 应付管理人报酬 |
11,550.44 |
11,633.52 |
9,502.67 |
7,911.93 |
| 应付托管费 |
3,465.10 |
3,490.06 |
2,850.80 |
2,373.59 |
| 应付销售服务费 |
42,184.99 |
46,936.95 |
44,978.04 |
31,496.32 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
14,962.35 |
75,016.86 |
- |
9,919.89 |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
81,822.86 |
165,000.00 |
81,822.86 |
155,000.00 |
| 负债合计 |
18,588,644.87 |
11,021,133.84 |
11,072,127.68 |
3,746,203.10 |
| 所有者权益 |
| 实收基金 |
348,316,770.76 |
335,172,548.38 |
349,768,906.02 |
286,235,005.96 |
| 未分配利润 |
176,561,919.62 |
123,973,177.00 |
19,824,644.58 |
24,042,549.02 |
| 所有者权益合计 |
524,878,690.38 |
459,145,725.38 |
369,593,550.60 |
310,277,554.98 |
| 负债及所有者权益总计 |
543,467,335.25 |
470,166,859.22 |
380,665,678.28 |
314,023,758.08 |